On January 24, 2025, biodrook co-founder and CTO Mykhailo Pluzhnyk presented his report “Biopolymers in Real-World 3D Printing” at the IV International Symposium “Modern Technologies in Medical Materials Science in Orthobiology.” This event brought together leading experts in medical materials science, orthopedics, and regenerative medicine.

Mykhailo shared his experience using biopolymers in 3D printing, highlighted the latest industry trends, and discussed the innovations being developed and implemented as part of the biodrook project. It is gratifying that this presentation made a significant contribution to expanding knowledge about additive technologies in regenerative medicine.

Special attention should be paid to the scale of the event, which served as a platform for the exchange of ideas among leading scientists, doctors, and technologists. We are grateful to the organizers—the Bogomolets National Medical University and the relevant institutes—for the opportunity to be part of this incredible initiative. Special thanks to Volodymyr Serhiyovych Chorny.

We also express our gratitude to the other speakers who shared their knowledge and experience, as it is precisely through such collaboration that the conditions for breakthrough discoveries are created.

Stay tuned for updates to learn more about our participation in similar events and the achievements of the biodrook team!

Translated with DeepL.com (free version)

Standardized implants often fail to take the most important factor into account—the patient.

Customized shape modeling, biocompatible materials, and surgical precision are not the future, but a modern requirement for bone reconstruction. At biodrook, we are convinced that personalized solutions are what reduce postoperative pain, accelerate healing, and prevent repeat procedures.

Unlike traditional titanium or universal implants, we use two types of biopolymers—bioresorbable and non-bioresorbable—depending on the clinical task and the patient’s needs. Products are custom-made based on medical images, and production is fully localized in Ukraine.

Just as with the development of antibiotics, a true breakthrough in bone surgery occurs when technology adapts to living biology, rather than the other way around. Every patient should receive a solution that corresponds specifically to their anatomy, age, and bone tissue condition.

That is why we do not offer a “one-size-fits-all” solution. Our manufacturing platform enables scalable customization—implants tailored to a specific individual, yet produced quickly, precisely, and in compliance with all medical standards.

We are expanding our manufacturing operations in Ukraine and seeking partnerships with clinics and research teams.

The future is personalized. And it is already in the clinical trial stage Translated with DeepL.com (free version)

CONTACT US

info@biodrook.com

Start building the future of accessible biotechnology with biodrook today!